IMPACT OF INTEGRASE INHIBITORS ON CARDIOVASCULAR EVENTS IN PERSONS STARTING ART
Background: Integrase strand transfer inhibitors (INSTI) have become essential components of antiretroviral therapy (ART). A recent study suggests that INSTI-based ART may lead to an increased risk for cardiovascular (CVD) events in the first two years compared to other ART combinations. However, analyzing treatment-naïve and treatment-experienced individuals together may have introduced bias. We estimated the…